Influenza Virus Infection and Shedding in Humans
Author Information
Author(s): Nishit Shetty, Meredith J. Shephard, Nicole C. Rockey, Hollie Macenczak, Jessica Traenkner, Shamika Danzy, Nahara Vargas-Maldonado, Peter J. Arts, Valerie Le Sage, Evan J. Anderson, G. Marshall Lyon, Eric Charles Fitts, Dalia A. Gulick, Aneesh K. Mehta, Mikhael F. El-Chami, Colleen S. Kraft, Krista R. Wigginton, Anice C. Lowen, Linsey C. Marr, Nadine G. Rouphael, Seema S. Lakdawala
Primary Institution: Emory University
Hypothesis
What are the dynamics of influenza virus shedding and symptom progression in a controlled human infection model?
Conclusion
The study demonstrates the safety and utility of a controlled human infection model to study influenza virus transmission dynamics.
Supporting Evidence
- Six out of eight participants were confirmed to be infected with the influenza virus.
- Viral shedding was observed in multiple physiological compartments including saliva and aerosols.
- Participants with higher viral loads showed a significant increase in antibody titers by day 15.
Takeaway
Researchers studied how the flu spreads by infecting eight volunteers and watching how they got sick and shed the virus.
Methodology
Participants were intranasally inoculated with H3N2 influenza virus, and symptoms and viral shedding were monitored over 15 days.
Potential Biases
Potential bias in participant selection and reporting of symptoms.
Limitations
The small sample size and the controlled environment may not fully represent natural infection dynamics.
Participant Demographics
Participants were aged 20 to 45, with a mix of races and ethnicities.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website